Hüseyin S. Bozkurt,MD,AGAF ✓

@HSEYNSANCARBOZ1 · joined 28 Oct 2020

3 awards,3 continent about Bifido 1- @AmerGastroAssn 2- @my_UEG 3-Korean Gastro Society. Bifido Algorithm Solver . Founder of Bioprobif, USA 🇺🇸 O-1A owner.

16 637Followers

163Following

4 968Posts total

108.3KViews on collected posts

โพสต์ล่าสุด

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ16 Sep

https://t.co/Cxkq7VG1GV 🇧🇷 Kanalizasyon 🕳️ arıtma sonucu kalan çamurdan gübre elde edip kullanmaya başladı 👏👏👏 Biz mi? Yıllar önceki çözüm projelerimizi gebze @Tubitak anlattığımızda onlara mı anlatıyoruz , duvara mı anlatıyoruz anlayamadık…. halen çamuru atıyorlar veya https:/ 758 views · 4 likes · 4 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ16 Sep

🤖 AI 👉Matematik 🧬Biyoloji 👇 Stable Biopolymeric Structure (Abiogenesis) + H⁺/OH⁻ (pH Gradient → Unstable Zeta Potential → Electrochemical Reaction) = Biogenesis Yani kısaca 👉Fizik+Matematik+Kimya Her kim , yapay zeka “ilaç,tedavi” buldu/yaptı derse, arkasında gerçek 836 views · 6 likes · 3 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ16 Sep

@YannickBuccella It is based on "unstable zeta potential"/“unstable entropy"—concepts from physics that underpin biology. This is a situation that this AI could never resolve on its own 1K views · 4 likes · 1 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ15 Sep

Pankreas kanserinde çok sınırlı kullanımı olabilecek ve aylık 40.000 💵 maliyetli KRAS tedavisi ne yazık ki Akciğer 🫁 kanserinden sonra Kolon kanserindede geri çekildi ( tıpkı mRNA bazlı tedavi gibi) Epigenetik faktörler artık mutasyonel faktörlerden çok daha baskın 9.7K views · 33 likes · 3 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ15 Sep

@GIMedOnc The likelihood of success for any treatment (including chemotherapy) that does not take dysbiosis into account is very low. 11.9K views · 7 likes · 1 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ15 Sep

And just like that, adagrasib + cetuximab is no longer FDA approved for KRAS G12C colorectal cancer. The accelerated approval was officially withdrawn September 1 after KRYSTAL-10 failed to confirm benefit. We talked about KRYSTAL-10 when it was presented earlier this year. 47.4K views · 112 likes · 41 reposts · 12 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ14 Sep

👏👏👏 572 views · 0 likes · 1 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ129 Aug

@YannickBuccella Oncology in CRC management is the fourth stage; unfortunately, any cancer treatment method that fails to account for intestinal dysbiosis will yield negative results. 4.2K views · 6 likes · 2 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ114 Jul

@HSEYNSANCARBOZ1 hocam merhaba, randevu için sitenizdeki mail adresinizden iletişim kurmaya çalıştım ancak mail geçersiz gözüküyor. Konu hakkında size nasıl ulaşabilirim acaba? 33 views · 0 likes · 0 reposts · 0 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ131 Jan 2025

https://t.co/2vtX7PUtBN 31.8K views · 29 likes · 2 reposts · 1 replies Open on X →

Hüseyin S. Bozkurt,MD,AGAF ✓@HSEYNSANCARBOZ121 Mar 2022

Bifidobakterinin 2 gücü : 1- mikroplastiklerin tamamen yok edilmesi 2-İnanılmaz biohybrid malzeme özelliği … İşte örnek : 1 tonluk mikroplastik biodegradasyonu sonucu kalan su 💧 yu tarım ve ziraate kazandırmanın yanında biodegradasyon sonucu 400 kg lık potansiyel gübre ++ https:/ 0 views · 11 likes · 5 reposts · 1 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

9 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม แสดงในวงกว้าง แต่มีผู้ชมตอบสนองน้อย.

ยอดดูมัธยฐาน1 033บัญชีนี้1 026ค่ามัธยฐานของ 10K–100K

การเข้าถึง, %6.21%บัญชีนี้3.75%ค่ามัธยฐานของ 10K–100K

การมีส่วนร่วม, %0.36%บัญชีนี้1.68%ค่ามัธยฐานของ 10K–100K

ตัวชี้วัด	บัญชีนี้	ค่ามัธยฐานของ 10K–100K	อัตราส่วน
ยอดดูมัธยฐานต่อโพสต์	1 033	1 026	1.01×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)	6.21%	3.75%	1.66×
อัตราการมีส่วนร่วม	0.36%	1.68%	0.21×

บัญชีอื่นในช่วงนี้ → เปรียบเทียบกับบัญชีอื่น → ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

31.8K31 Jan

3314 Jul

4.2K29 Aug

5724 Sep

47.4K5 Sep

11.9K

9.7K

1K6 Sep

836

758

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.10%31 Jan

0.00%14 Jul

0.21%29 Aug

0.17%4 Sep

0.36%5 Sep

0.08%

0.39%

0.48%6 Sep

1.08%

1.06%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.68%.

What the audience does

Likes57.4%201 in total

Reposts16.6%58 in total

Replies3.7%13 in total

Quotes2.3%8 in total

Bookmarks20.0%70 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

โพสต์ล่าสุด

เทียบกับบัญชีขนาดเดียวกัน

Growth & engagement

Views per post

Engagement rate per post

What the audience does

บัญชีที่คล้ายกัน